SLC3A2 and colorectal carcinoma: Since the above data confirmed that the CD98hcECTO antibody was able to bind cell surface CD98hc and internalized to the lysosomes of CRC cells, we decided to use it as a skeleton to construct an anti-CD98hc ADC, using as a payload the antimicrotubular agent DM1.